The hyperphagic effect of nociceptin/orphanin FQ in rats

Peptides

Volumn 21, Issue 7, 2000, Pages 1051-1062

  Polidori, Carlo ^a   De Caro, Giuseppe ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Food intake; Nociceptin; Nocistatin; ORL1 receptor agonists; ORL1 receptor antagonists; Orphanin FQ; Water intake

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIGAND; NEUROTRANSMITTER; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; NOCISTATIN; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; BEHAVIOR; BRAIN REGION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FEEDING; FLUID INTAKE; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS NUCLEUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0033811837     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00243-6     Document Type: Article

References (108)

1. Allen Y.S., Adrian T.E., Allen J.M., et al. Neuropeptide Y distribution in the rat brain. Science. 221:1983;877-879.
2. Allen C.N., Jiang Z.G., Teshima K., et al. Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons. J Neurosci. 19:1999;2152-2160.
3. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol. 368:1996;229-251.
4. Baskin D.G., Breininger J.F., Schwartz M.W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 48:1999;828-833.
5. Baskin D.G., Hahn T.M., Schwartz M.W. Leptin sensitive neurons in the hypothalamus. Horm Metab Res. 31:1999;345-350.
6. A receptor stimulation within the nucleus accumbens shell regional mapping and characterization of macronutrient and taste preference . Behav Neurosci. 113:1999;324-336.
7. Bigoni R., Giuliani S., Calo' G., et al. Characterization of nociceptin receptors in the periphery in vitro and in vivo studies . Naunyn-Schmiedeberg's Arch Pharmacol. 359:1999;160-167.
8. Boom A., Mollereau C., Meunier J.C., et al. Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system. Neuroscience. 91:1999;991-1007.
9. Brown D.R., Holtzman S.G. Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol Biochem Behav. 11:1979;567-573.
10. Bunzow J.R., Saez C., Mortrud M., et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, Δ or κ opioid receptor type. FEBS Lett. 347:1994;284-288.
11. 2 is an agonist of the nociceptin (ORL1) receptor. Eur J Pharmacol. 349:1998;R5-R6.
12. 2, a novel selective nociceptin receptor; antagonist. In: 1999 INRC Meeting, Saratoga Springs: NY, USA, 10-15 July 1999.
13. Calo' G., Rizzi A., Bodin M., et al. Pharmacological characterization of nociceptin receptor an in vitro study . Can J Physiol Pharmacol. 75:1997;713-718.
14. Calo' G., Rizzi A., Marzola G., et al. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol. 125:1998;373-378.
15. Candeletti S., Ferri S. Prolonged effects of centrally administered nociceptin in the rat. Regul Pept. 80:1999;123.
16. 2 on nociception in rats. In: 29th International Narcotic Research Conference, A 170, Garmisch-Partenkirchen, Germany, 20-25 July 1998.
17. 2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol. 125:1998;949-951.
18. Catania A., Lipton J.M. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev. 14:1993;564-576.
19. Chen Y., Fans Y., Liu J., et al. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
20. Contreras R.J., Kosten T., Bird E. Area postrema part of the autonomic circuitry of caloric homeostasis . Fed Proc. 43:1984;2966-2968.
21. Cooper S.J., Gilbert D.B. Naloxone suppresses fluid consumption in tests of choice between sodium chloride solutions and water in male and female water-deprived rats. Psychopharmacology. 84:1984;362-367.
22. Cooper S.J., Jackson A., Kirkham T.C. Endorphins and food intake kappa opioid receptor agonists and hyperphagia . Pharmacol Biochem Behav. 23:1985;889-901.
23. Corp E.S. The receptor basis of neuropeptide Y-induced food intake. Cooper S.J., Clifton P.G. Drug receptor subtypes and ingestive behaviour. 1996;323-346 Academic Press, London.
24. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin. A role in pain and analgesia, but so much more. Trends Neurosci. 21:1998;215-221.
25. Devine D.P., Taylor L., Reinscheid R.K. , Monsma FJJr, Civelli O, Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res. 21:1996;1387-1396.
26. Dourish C.T. 5-HT receptors subtypes and feeding behaviour. Adv Biosci. 85:1992;179-202.
27. Dube M.G., Horvath T.L., Leranth C., Kalra P.S., Kalra S.P. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav. 56:1994;811-813.
28. Emmerson P.J., Miller R.J. Pre- and post-synaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J Physiol. 517:1999;431-445.
29. Fukuda K., Kato S., Mori K., et al. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
30. Giraudo S.Q., Billington C.J., Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat. Brain Res. 782:1998;18-23.
31. Gosnell B.A. , Involvement of mu opioid receptors in the amygdala in the control of feeding. Neuropharmacology. 27:1998;319-326.
32. Grandison L., Guidotti A. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology. 16:1977;533-536.
33. Grill H.J., Ginsberg A.B., Seeley R.J., Kaplan J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci. 18:1998;10128-10135.
34. 2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo. Eur J Pharmacol. 357:1998;R1-R3.
35. Guerrini R., Calo' G., Bigoni R., et al. Further studies on nociceptin related peptides discovery of new molecules with antagonist activity on the nociceptin receptor . Regul Pept. 80:1999;124.
36. Guerrini R., Calo' G., Rizzi A., et al. A new selective antagonist of the nociceptin receptor. Br J Pharmacol. 123:1998;163-165.
37. 1A receptor antagonist, WAY-100635, is dependent on the phase of the light-dark cycle. In: Louilot D, Durkin T, Spampinato U, Cador M, editors. Monitoring molecules in neuroscience. 1995. p. 211-2.
38. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem Biophys Res Commun. 219:1996;714-719.
39. Huszar D., Lynch C.A., Fiarchild-Huntress V., et al. Targeted disruption of the melanocortin-4-receptor results in obesity in mice. Cell. 88:1997;131-141.
40. Inui A. Feeding and body weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci. 22:1999;62-67.
41. Jackson H.C., Griffin I.J., Nutt D.J. Endogenous opioids may be involved in idazoxan-induced food intake. Neuropharmacology. 31:1992;771-776.
42. Jenck F., Moreau J.L., Martin J.R., et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA. 94:1997;14854-14859.
43. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA. 88:1991;10931-10935.
44. Kapusta D.R., Sezen S.F., Chang J.K., Lippton H., Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci. 60:1997;15-21.
45. Kask A., Mutulis F., Muceniece R., et al. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024) evaluation in vitro and in vivo . Endocrinology. 139:1998;5006-5014.
46. Kask A., Rago L., Mutulis F., Pahkla R., Wikberg J.E.S., Schioth H.B. Selective antagonist for the melanocortin-4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Commun. 245:1998;90-93.
47. Khachaturian H., Lewis M.E., Shafer M.K.H., Watson S.J. Anatomy of the CNS opioid systems. Trends Neurosci. 8:1985;111-119.
48. Kiss J.Z., Cassell M.D., Palkovits M. Analysis of the ACTH/β-End/α-MSH-immunoreactive afferent input to the hypothalamic paraventricular nucleus of the rat. Brain Res. 324:1984;91-99.
49. Koch J.E., Glass M.J., Cooper M.L., Bodnar R.J. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience. 66:1995;951-957.
50. Koster A., Montkowski A., Schulz S., et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA. 96:1999;10444-10449.
51. Kotz C.M., Billington C.J., Levine A.S. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am J Physiol. 272:1997;R1028-R1032.
52. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effect of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest. 96:1995;163-170.
53. Lapalu S., Moisand C., Mazarguil H., Cambois G., Mollereau C., Meunier J.C. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Lett. 417:1997;333-336.
54. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol. 349:1998;R1-R3.
55. Leventhal L., Stevens L.B., Rossi G.C., Pasternak G.W., Bodnar R.J. Antisense mapping of the MOR-1 opioid receptor clone modulation of hyperphagia induced by DAMGO . J Pharmacol Exp Ther. 282:1997;1402-1407.
56. Levine A.S., Morley J.E. Neuropeptide Y a potent inducer of consummatory behavior in rats . Peptides. 5:1984;1025-1029.
57. Lowi M.T., Maickel R.P., Yim G.K.W. Naloxone reduction of stress-related feeding. Life Sci. 26:1980;2113-2118.
58. Madeddu P., Salis M.B., Milia A.F., et al. Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension. 33:1999;914-919.
59. Malek J.A., Widdowson P.S., Harrols J.A., McKnight A.T., Williams G. Changes in nociceptin receptor density in dietary-obese rats. Br J Pharmacol. 126:1999;267P.
60. Meis S., Pape H.C. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanic FQ. J Neurosci. 18:1998;8133-8144.
61. Meunier J.C. Nociceptin/orphanin FQ, and the opioid receptor-like ORL1 receptor. Eur J Pharmacol. 340:1997;1-15.
62. Meunier J.C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature (London). 377:1995;532-535.
63. Minami T., Okuda-Ashitaka E., Nishiuchi Y., et al. Anti-nociceptive responses produced by human putative counterpart of nocistatin. Br J Pharmacol. 124:1998;1016-1018.
64. Mollereau C., Parmentier M., Mailleux P., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
65. Morley J.E., Levine A.S. Dynorphin, an endogenous stimulator of feeding. Prog Clin Biol Res. 192:1985;293-300.
66. Morley J.E., Levine A.S. Dynorphin-(1-13) induces spontaneous feeding in rats. Life Sci. 29:1981;1901-1903.
67. Morley J.E., Levine A.S. Stress-induced eating is mediated through endogenous opiates. Science. 209:1980;1259-1260.
68. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem. 73:1999;179-186.
69. 125I)-[(14)Tyr]-orphanin FQ binding . J Comp Neurol. 412:1999;563-605.
70. 2 at the ORL1 receptor of central and peripheral sites. In: 29th International Narcotic Research Conference, A 129, Garmisch-Partenkirchen, Germany, 20-25 July, 1998.
71. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol 119:1081-3.
72. 2 in rat brain, vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol. 127:1999;123-130.
73. Okuda-Ashitaka E., Minami T., Tachibana S., et al. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature (London). 392:1998;286-289.
74. 2 act as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells. NeuroReport. 10:1999;1127-1131.
75. Paxinos G., Watson C. The rat brain in stereotaxic coordinates (2nd ed.). 1986;Academic Press, North Ryde, N.S.W., Australia.
76. Poggioli R., Vergoni A.V., Bertolini A. ACTH-(1-24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides. 7:1986;843-848.
77. Pohorecky L.A., Blakely G.G., Benjamin D. Antisense knockdown of ORL-1 receptor results in increased ethanol-induced locomotor activation and attenuation of the circadian rhythm of body temperature and water consumption in rats. Alcohol Clin Exp Res. 22:(Suppl.):1998;159A.
78. Polidori C., Calo' G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia identification of a selective antagonist . Psychopharmacology. 148:2000;430-437.
79. 2]NC(1-13)NH2. Regul Pept. 80:1999;126.
80. Polidori C, Calo' G, Guerrini, R, Regoli D, Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia. XII International Conference on the Physiology of Fluid and Food Intake. Abstract Book. Pecs, Hungary: 5-8 July 1998.
81. Polidori C., Ciccocioppo R., Regoli D., Massi M. Neuropeptide Y receptor(s) mediating feeding in the rat characterization with antagonists . Peptides. 21:2000;29-35.
82. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
83. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr, Civelli O. Structures that delineate orphanin FQ and dynorphin-A pharmacological selectivities. J Biol Chem. 273:1998;1490-1495.
84. Reinscheid R.K., Nothacker H.P., Bourson A., et al. Orphanin FQ neuropeptide that activates an opioid-like G protein-coupled receptor . Science. 270:1995;792-794.
85. Rossi M., Kim M.S., Morgan D.G., et al. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of α-melanocyte stimulating hormone in vivo. Endocrinology. 139:1998;4428-4431.
86. Samanin R., Grignaschi G. Role of 5-hydroxytryptamine receptor subtypes in satiety and animal models of eating disorders. Cooper S.J., Clifton P.G. Drug receptor subtypes and ingestive behaviour. 1996;39-58 Academic Press, London.
87. Sato N., Ogawa Y., Katsuura G., et al. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett. 224:1997;149-152.
88. Sbrenna S., Marti M., Morari M., et al. 5-hydroxytryptamine, L-Glu and GABA efflux from rat cerebrocortical synaptosomes modulation by opioid receptor like 1 receptor . Regul Pept. 80:1999;127.
89. Schlicker E., Werthwein S., Kathmann M., Bauer U. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 358:1998;418-422.
90. Schulz S., Schreff M., Nuss D., Gramsch C., Hollt V. Nociceptin/orphanin FQ, and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. NeuroReport. 7:1996;3021-3025.
91. Shah S., Page C.P., Spina D. Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol. 125:1998;510-516.
92. Simansky K.J. 5-HT receptor subtypes influencing feeding and drinking focus on the periphery . Cooper S.J., Clifton P.G. Drug receptor subtypes and ingestive behaviour. 1996;323-346 Academic Press, London.
93. Sinchak K., Hendricks D.G., Baroudi R., Micevych P.E. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. NeuroReport. 22:1997;3857-3860.
94. 3H]-5-HT release from rat cerebral cortex slices. Br J Pharmacol. 128:1999;119-123.
95. South E.H., Ritter R.C. Over-consumption of preferred foods following capsaicin pretreatment of the area postrema and adjacent nucleus of the solitary tract. Brain Res. 288:1983;243-251.
96. Stapleton J.M., Lind M.D., Merriman V.J., Reid L.D. Naloxone inhibits diazepam-induced feeding in rats. Life Sci. 24:1979;2421-2425.
97. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport. 8:1997;423-426.
98. Stratford T.R., Kelley A.E. GABA in the nucleus accumbens shell partecipates in the central regulation of feeding behavior. J Neurosci. 17:1997;4434-4440.
99. A receptors in the medial ventral pallidum elicits feeding in satiated rats. Brain Res. 825:1999;199-203.
100. Stratford T.R., Swanson C.J., Kelley A.E. Specific changes in food intake elicited by blockade or activation of glutamate receptors in the nucleus accumbens shell. Behav Brain Res. 93:1998;43-50.
101. Sugrue M.F. Neuropharmacology of drugs affecting food intake. Pharmacol Ther. 32:1987;145-182.
102. Toll L, Burnside J, Berzetei-Gurske I. Agonist activity of ORL1 antagonists is dependent upon receptor number. In: International Narcotics Research Conference 1998, Garmisch-Partenkirchen, Germany, 20-25 July 1998; A89.
103. Vaughan C.W., Christie M.J. Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol. 117:1996;1609-1611.
104. Vergoni A.V., Poggioli R., Bertolini A. Corticotropin inhibits food intake in rats. Neuropeptides. 7:1986;153-158.
105. Xu I.S., Calo' G., Regoli D., Xu X.J., Wiesenfeld-Hallin Z. Effects of intrathecal nocistatin on the flexor reflex in the rat. Regul Pept. 80:1999;128.
106. 2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci Lett. 249:1998;127-130.
107. + conductance. Neuroendocrinology. 67:1998;73-82.
108. Weiss F., Koob G.F. The neuropharmacology of ethanol self-administration. Meyer R.E., Koob G.F., Lewis M.J., Paul S.M. Neuropharmacology of ethanol. 1991;125-162 Birkhauser, Boston, MA.